Business · 08/09/2000Updated: 10/17/2026 · 1 min read

FDA Authorizes Health Claims on Plant Sterol/Stanol Esters for Reduced Risk of Coronary Heart Disease

Summary

The FDA is allowing the use of health claims on food labels for plant sterol/stanol esters, which may help lower the risk of coronary heart disease, following petitions from Lipton and McNeil Consumer Healthcare.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 10/5/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Crisis Response

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a proposed data collection project, titled Public Health Crisis Response (PHCR) Cooperative Agreement, which aims to rapidly fund public health programs responding to major emergencies and crises, as required by the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/28/2026

CDC Invites Public Comment on Proposed Data Collection for Public Health Emergency Preparedness

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project, titled Public Health Emergency Preparedness (PHEP) Cooperative Agreement, as part of its efforts to reduce public burden and maximize the utility of government information, in accordance with the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/16/2026

NIH Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form

The National Institutes of Health (NIH) is proposing a web-based reporting form to help the Agency Intramural Research Integrity Officer (AIRIO) assess concerns and determine appropriate next steps in evaluating allegations of research misconduct.

Read summary →

Business · 9/16/2026

Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists

The Centers for Disease Control and Prevention (CDC) issued an Order under Sections 362 and 365 of the Public Health Service Act, continuing the suspension of introducing certain persons from countries with a quarantinable communicable disease outbreak.

Read summary →

Business · 9/15/2026

World Trade Center Health Program Petition for Peripheral Artery Disease Found Lacking in Evidence

The World Trade Center Health Program Administrator has denied a petition to add peripheral artery disease to the list of WTC-related health conditions due to insufficient evidence, and therefore will not request a recommendation from the WTC Health Program Scientific/Technical Advisory Committee or publish a proposed rule.

Read summary →

Business · 10/5/2026

CDC Requests Public Comment on Respiratory Protective Devices Data Collection

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project related to Respiratory Protective Devices, as required by the Paperwork Reduction Act of 1995, to inform the approval certification activities under 42 CFR part 84.

Read summary →